Malicious PyPI packages give hackers control of Telegram bot servers

A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...

Clean GitHub repo tricks AI coding agents into running malware

An agentic coding tool tasked with cloning and setting up a seemingly benign GitHub repository could execute a malicious ...
The Free Press Journal

Alembic Pharmaceuticals Incorporates Germany Subsidiary To Expand European Market Presence

Vadodara: Alembic Pharmaceuticals is taking a direct route into Europe, setting up a new entity in Germany to strengthen its international reach and tap into fresh growth opportunities. Establishes ...
The Free Press Journal

Alembic Pharmaceuticals Receives USFDA Approval For Cancer Injection, Expands Oncology Portfolio

Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in the US generics space with a key oncology and autoimmune therapy product.
Yahoo Finance

Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)

BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...
Business Line

Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drug

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...
The Hindu

U.S. FDA nod for Alembic Pharma’s generic of Sandoz’s ophthalmic solution

Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Pharmabiz

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
SiliconANGLE

Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Wall Street Journal

Accenture and Jeffrey Katzenberg’s WndrCo Invest in AI Marketing Startup

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...
VentureBeat

Alembic melted GPUs chasing causal A.I. — now it's running one of the fastest supercomputers in the world

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...